Atlas Trials

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Clinical trial NCT05389514 · TEMPORARILY_NOT_AVAILABLE

Trial details

NCT number
NCT05389514
Sponsor
Providence Health & Services
Status
TEMPORARILY_NOT_AVAILABLE
Study type
EXPANDED_ACCESS
KRAS G12V Mutant Advanced Epithelial Cancers

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.